Search

everythinglearnresearchcommunity

for

Search:↓

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Facial hair is crucial for transgender men's gender identity and transition.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Dutasteride and finasteride can change semen and hormone levels in men.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Applying estradiol to skin causes local changes but not cancer.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Sex hormones affect brain injury differently in males and females.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.